<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Patient Health Record</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Michael A Brunner</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">April 23, 1954 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>8616 HORIZON LN<br/>HUDSON, FL 34667-4159, US<br/><br/>Primary Home Phone:  352-737-0072<br/>Email:  gebomitch2003@yahoo.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">261414 2.16.840.1.113883.4.391.327187<br/>261414 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">a92bb57e-6600-48cc-92d2-d7ecdf019a76 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">June 7, 2024, 18:21:31 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Chirag Patel</td></tr><tr><td class="td_header_role_value internal_format">13906 LAKESHORE BLVD<br/>Suite 330<br/>HUDSON, FL 346671487, US<br/><br/>Tel:  727-863-5242<br/></td></tr></tbody></table></td></tr><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Eugene Turner</td></tr><tr><td class="td_header_role_value internal_format">13906 LAKESHORE BLVD<br/>Suite 330<br/>HUDSON, FL 346671487, US<br/><br/>Tel:  727-863-5242<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">Michelle Budrevic<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">315 N. Florida Ave<br/>Brooksville, FL 34601, US<br/><br/>Tel:  352-340-7266<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Michael Brunner<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  352-737-0072<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medical (General) History</a></li><li><a href="#id18">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">Venipuncture-998085</span><br/>Reviewed date:12/20/2023 09:17:18 AM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/></td></tr><tr><td colspan="4"><span class="content_span">TSH reflex to T4</span><br/>Reviewed date:12/15/2023 09:40:10 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result2_attr1">TSH</td><td>1.360</td><td>0.450-4.500 uIU/mL</td><td/></tr><tr><td colspan="4"><span class="content_span">CMP14+eGFR-334943</span><br/>Reviewed date:12/15/2023 09:40:36 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result3_attr1">Glucose</td><td>98</td><td>70-99 mg/dL</td><td/></tr><tr><td ID="result3_attr2">BUN</td><td>6</td><td>8-27 mg/dL</td><td/></tr><tr><td ID="result3_attr3">Creatinine</td><td>0.85</td><td>0.76-1.27 mg/dL</td><td/></tr><tr><td ID="result3_attr4">eGFR</td><td>94</td><td>&gt;59 mL/min/1.73</td><td/></tr><tr><td ID="result3_attr5">BUN/Creatinine Ratio</td><td>7</td><td>10-24</td><td/></tr><tr><td ID="result3_attr6">Sodium</td><td>140</td><td>134-144 mmol/L</td><td/></tr><tr><td ID="result3_attr7">Potassium</td><td>4.6</td><td>3.5-5.2 mmol/L</td><td/></tr><tr><td ID="result3_attr8">Chloride</td><td>105</td><td>96-106 mmol/L</td><td/></tr><tr><td ID="result3_attr9">Carbon Dioxide, Total</td><td>24</td><td>20-29 mmol/L</td><td/></tr><tr><td ID="result3_attr10">Calcium</td><td>9.6</td><td>8.6-10.2 mg/dL</td><td/></tr><tr><td ID="result3_attr11">Protein, Total</td><td>7.0</td><td>6.0-8.5 g/dL</td><td/></tr><tr><td ID="result3_attr12">Albumin</td><td>4.5</td><td>3.9-4.9 g/dL</td><td/></tr><tr><td ID="result3_attr13">Globulin, Total</td><td>2.5</td><td>1.5-4.5 g/dL</td><td/></tr><tr><td ID="result3_attr14">A/G Ratio</td><td>1.8</td><td>1.2-2.2</td><td/></tr><tr><td ID="result3_attr15">Bilirubin, Total</td><td>0.4</td><td>0.0-1.2 mg/dL</td><td/></tr><tr><td ID="result3_attr16">Alkaline Phosphatase</td><td>63</td><td>44-121 IU/L</td><td/></tr><tr><td ID="result3_attr17">AST (SGOT)</td><td>21</td><td>0-40 IU/L</td><td/></tr><tr><td ID="result3_attr18">ALT (SGPT)</td><td>14</td><td>0-44 IU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">PSA (Reflex To Free) (Serial)-480640</span><br/>Reviewed date:12/15/2023 09:40:57 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result4_attr1">Prostate Specific Ag</td><td>0.7</td><td>0.0-4.0 ng/mL</td><td ID="result4_attr1_notes"><p>Roche ECLIA methodology.</p><p>                                                                     .</p><p>According to the American Urological Association, Serum PSA should</p><p>decrease and remain at undetectable levels after radical</p><p>prostatectomy. The AUA defines biochemical recurrence as an initial</p><p>PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory</p><p>PSA value 0.2 ng/mL or greater.</p><p>Values obtained with different assay methods or kits cannot be used</p><p>interchangeably. Results cannot be interpreted as absolute evidence</p><p>of the presence or absence of malignant disease.</p></td></tr><tr><td ID="result4_attr2">PDF</td><td>.</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">Lipid Panel-303756</span><br/>Reviewed date:12/15/2023 09:40:16 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result5_attr1">Cholesterol, Total</td><td>192</td><td>100-199 mg/dL</td><td/></tr><tr><td ID="result5_attr2">Triglycerides</td><td>67</td><td>0-149 mg/dL</td><td/></tr><tr><td ID="result5_attr3">HDL Cholesterol</td><td>52</td><td>&gt;39 mg/dL</td><td/></tr><tr><td ID="result5_attr4">VLDL Cholesterol Cal</td><td>12</td><td>5-40 mg/dL</td><td/></tr><tr><td ID="result5_attr5">LDL Chol Calc (NIH)</td><td>128</td><td>0-99 mg/dL</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC With Differential/Platelet-005009</span><br/>Reviewed date:12/15/2023 09:40:28 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result6_attr1">WBC</td><td>5.4</td><td>3.4-10.8 x10E3/uL</td><td/></tr><tr><td ID="result6_attr2">RBC</td><td>4.57</td><td>4.14-5.80 x10E6/uL</td><td/></tr><tr><td ID="result6_attr3">Hemoglobin</td><td>15.4</td><td>13.0-17.7 g/dL</td><td/></tr><tr><td ID="result6_attr4">Hematocrit</td><td>44.6</td><td>37.5-51.0 %</td><td/></tr><tr><td ID="result6_attr5">MCV</td><td>98</td><td>79-97 fL</td><td/></tr><tr><td ID="result6_attr6">MCH</td><td>33.7</td><td>26.6-33.0 pg</td><td/></tr><tr><td ID="result6_attr7">MCHC</td><td>34.5</td><td>31.5-35.7 g/dL</td><td/></tr><tr><td ID="result6_attr8">RDW</td><td>12.7</td><td>11.6-15.4 %</td><td/></tr><tr><td ID="result6_attr9">Platelets</td><td>235</td><td>150-450 x10E3/uL</td><td/></tr><tr><td ID="result6_attr10">Neutrophils</td><td>48</td><td>Not Estab. %</td><td/></tr><tr><td ID="result6_attr11">Lymphs</td><td>30</td><td>Not Estab. %</td><td/></tr><tr><td ID="result6_attr12">Monocytes</td><td>12</td><td>Not Estab. %</td><td/></tr><tr><td ID="result6_attr13">Eos</td><td>9</td><td>Not Estab. %</td><td/></tr><tr><td ID="result6_attr14">Basos</td><td>1</td><td>Not Estab. %</td><td/></tr><tr><td ID="result6_attr15">Neutrophils (Absolute)</td><td>2.6</td><td>1.4-7.0 x10E3/uL</td><td/></tr><tr><td ID="result6_attr16">Lymphs (Absolute)</td><td>1.6</td><td>0.7-3.1 x10E3/uL</td><td/></tr><tr><td ID="result6_attr17">Monocytes(Absolute)</td><td>0.6</td><td>0.1-0.9 x10E3/uL</td><td/></tr><tr><td ID="result6_attr18">Eos (Absolute)</td><td>0.5</td><td>0.0-0.4 x10E3/uL</td><td/></tr><tr><td ID="result6_attr19">Baso (Absolute)</td><td>0.0</td><td>0.0-0.2 x10E3/uL</td><td/></tr><tr><td ID="result6_attr20">Immature Granulocytes</td><td>0</td><td>Not Estab. %</td><td/></tr><tr><td ID="result6_attr21">Immature Grans (Abs)</td><td>0.0</td><td>0.0-0.1 x10E3/uL</td><td/></tr><tr><td colspan="4"><span class="content_span">Hemoglobin A1c-001453</span><br/>Reviewed date:12/15/2023 09:40:04 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result7_attr1">Hemoglobin A1c</td><td>5.2</td><td>4.8-5.6 %</td><td ID="result7_attr1_notes"><p>                                                       .</p><p>         Prediabetes: 5.7 - 6.4</p><p>         Diabetes: &gt;6.4</p><p>         Glycemic control for adults with diabetes: &lt;7.0</p></td></tr><tr><td colspan="4"><span class="content_span">Cardiovascular Report-910385</span><br/>Reviewed date:12/15/2023 09:41:06 AM<br/>Interpretation:<br/>Performing Lab:Labcorp Tampa, 5610 W LaSalle Street, Tampa, Phone - 8008775227, Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result8_attr1">Interpretation</td><td>Note</td><td/><td ID="result8_attr1_notes"><p>-------------------------------</p><p>CARDIOVASCULAR REPORT:</p><p>-------------------------------</p><p>Current available clinical information suggests the</p><p>patient's risk is at least LOW. One major CHD risk factor is</p><p>present (age over 45). If the patient has CHD or a CHD risk</p><p>equivalent, the risk category is high. If patient does not</p><p>have CHD or a CHD risk equivalent, consider use of the</p><p>Pooled Cohort Equations to estimate 10-year CVD risk, as</p><p>individuals with greater than 7.5% risk may warrant more</p><p>intensive therapy. The calculator can be found at:</p><p>http://tools.cardiosource.org/ASCVD-Risk-Estimator/</p><p>-</p><p>Insulin resistance, obesity, excessive alcohol use, smoking,</p><p>nephrotic syndrome, liver disease, and certain medications</p><p>can cause secondary dyslipidemia. Consider evaluation if</p><p>clinically indicated.</p><p>-</p><p>Therapeutic lifestyle changes are always valuable to achieve</p><p>optimal blood lipid status (diet, exercise, weight</p><p>management).</p><p>-------------------------------</p><p>LIPID MANAGEMENT</p><p>Select one patient risk category based upon medical history</p><p>and clinical judgment. Additional risk factors such as</p><p>personal or family history of premature CHD, smoking, and</p><p>hypertension modify a patient's goals of therapy. In CVD</p><p>prevention, the intensity of therapy should be adjusted to</p><p>the level of patient risk. MODERATE intensity statin therapy</p><p>generally results in an average LDL-C reduction of 30% to</p><p>less than 50% from the untreated baseline. Examples include</p><p>(daily doses): atorvastatin 10-20 mg, rosuvastatin 5-10 mg,</p><p>simvastatin 20-40 mg, pravastatin 40-80 mg, lovastatin 40</p><p>mg. HIGH intensity statin therapy generally results in an</p><p>average LDL-C reduction of 50% or more from the untreated</p><p>baseline. Examples include (daily doses): atorvastatin 40-80</p><p>mg and rosuvastatin 20 mg.</p><p>LOW RISK ASSESSMENT AND TREATMENT SUGGESTIONS</p><p>-------------------------------</p><p>LDL-C is acceptable, was 99 and now is 128 mg/dL. Non-HDL</p><p>Cholesterol is acceptable, was 110 and now is 140 mg/dL.</p><p>-</p><p>Considerations for use of statin therapy include family</p><p>history of premature atherosclerotic disease, elevated</p><p>coronary artery calcium score, ankle-brachial index &lt; 0.9,</p><p>elevated CRP, or elevated 10-year CVD risk.</p><p>INTERMEDIATE RISK ASSESSMENT AND TREATMENT SUGGESTIONS</p><p>-------------------------------</p><p>LDL-C is acceptable, was 99 and now is 128 mg/dL. Non-HDL</p><p>Cholesterol is acceptable, was 110 and now is 140 mg/dL.</p><p>-</p><p>Consider measurement of LDL particle number or Apo B to</p><p>adjudicate need for further LDL lowering therapy. Consider</p><p>beginning or increasing statin. Factors that may influence</p><p>statin use include family history of premature</p><p>atherosclerotic disease, elevated coronary artery calcium</p><p>score, ankle-brachial index &lt; 0.9, elevated CRP, or elevated</p><p>10-year CVD risk. If statin cannot be tolerated or</p><p>increased, alternatives include use of an intestinal agent</p><p>(ezetimibe or bile acid sequestrant) or niacin.</p><p>HIGH RISK ASSESSMENT AND TREATMENT SUGGESTIONS</p><p>-------------------------------</p><p>LDL-C is borderline high, was 99 and now is 128 mg/dL.</p><p>Non-HDL Cholesterol is borderline high, was 110 and now is</p><p>140 mg/dL.</p><p>-</p><p>Begin statin. If statin already in use, consider increasing</p><p>dose to achieve at least a 50% LDL reduction from baseline.</p><p>Moderate or high intensity statin is preferred. If statin</p><p>cannot be tolerated or increased, alternatives include use</p><p>of an intestinal agent (ezetimibe or bile acid sequestrant)</p><p>or niacin.</p><p>-------------------------------</p><p>DISCLAIMER</p><p>These assessments and treatment suggestions are provided as</p><p>a convenience in support of the physician-patient</p><p>relationship and are not intended to replace the physician's</p><p>clinical judgment. They are derived from national guidelines</p><p>in addition to other evidence and expert opinion. The</p><p>clinician should consider this information within the</p><p>context of clinical opinion and the individual patient.</p><p>SEE GUIDANCE FOR CARDIOVASCULAR REPORT: Grundy SM et al.</p><p>2018 Multisociety guideline on the management of blood</p><p>cholesterol: a report of the American College of</p><p>Cardiology/American Heart Association Task Force on Clinical</p><p>Practice Guidelines. J Am Coll Cardiol 2019; 73: e285-350;</p><p>Contois et al. Clin Chem 2009; 55(3):407-419; Brunzell et</p><p>al. Diabetes Care 2008; 31(4):811-82.</p></td></tr><tr><td ID="result8_attr2">PDF</td><td>Not applicable</td><td/><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div>No Information</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Meloxicam 7.5 MG</td><td ID="instruction1">TAKE 1 TABLET BY MOUTH EVERY DAY for 90</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">Fluad HD</td><td>Unknown</td><td>12/20/2023</td><td>Refused</td><td/></tr><tr><td ID="immunization2">Influenza (split), 3 yrs and above</td><td>Unknown</td><td>12/16/2021</td><td>Refused</td><td ID="immunization2notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization3">Influenza, Fluzone High Dose Quad</td><td>SC Subcutaneous</td><td>10/03/2022</td><td>Administered</td><td ID="immunization3notes"><p>Lot#52AP</p><p>Exp-06/30/2023</p><p>NDC #19515-808-52</p></td></tr><tr><td ID="immunization4">Moderna Covid-19 Vaccine 1st dose</td><td>Unknown</td><td>07/11/2022</td><td>Refused</td><td ID="immunization4notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization5">Pneumococcal polysaccharide PPV23</td><td>Unknown</td><td>12/16/2021</td><td>Refused</td><td ID="immunization5notes">  Immunization Given by from source eCW:: </td></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div>No Information</div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Alcohol dependence (66590003)</td><td ID="Problem1">Alcohol dependence, uncomplicated (F10.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>55822004</td><td ID="Problem2">Hyperlipidemia (E78.5)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>201819000</td><td ID="Problem3">Primary OA (M15.0)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>66590003</td><td ID="Problem4">Alcohol dependence, daily use (F10.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>191891003</td><td ID="Problem5">Marijuana use (F12.90)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>78 /min</td><td>12/20/2023</td><td/></tr><tr><th ID="vital2">Temperature</th><td>97.6 degrees Fahrenheit</td><td>12/20/2023</td><td/></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>70 mm Hg</td><td>12/20/2023</td><td/></tr><tr><th ID="vital4">Oximetry</th><td>98 %</td><td>12/20/2023</td><td/></tr><tr><th ID="vital5">Height-cm</th><td>175.26 cm</td><td>12/20/2023</td><td/></tr><tr><th ID="vital6">Weight-kg</th><td>75.3 kg</td><td>12/20/2023</td><td/></tr><tr><th ID="vital7">Height</th><td>69 in</td><td>12/20/2023</td><td/></tr><tr><th ID="vital8">Blood pressure systolic</th><td>128 mm Hg</td><td>12/20/2023</td><td/></tr><tr><th ID="vital9">Weight</th><td>166 lbs</td><td>12/20/2023</td><td/></tr><tr><th ID="vital10">BMI</th><td>24.51 kg/m2</td><td>12/20/2023</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">No Information</span></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>06/14/2023</td><td>Chirag Patel</td><td>HLD (HYPERLIPIDEMIA) E78.5</td></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>06/21/2023</td><td>Eugene Turner</td><td>Hyperlipidemia E78.5 ; Primary OA M15.0 ; Nevus, non-neoplastic I78.1 ; Marijuana use F12.90 ; Alcohol dependence, daily use F10.20 ; COVID-19 vaccination declined Z28.21 ; BMI 25-25.9 Z68.25 ; Dietary counseling Z71.3 and Annual visit for general adult medical examination with abnormal findings Z00.01</td></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>12/13/2023</td><td>Chirag Patel</td><td>Hyperlipidemia E78.5</td></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>12/20/2023</td><td>Eugene Turner</td><td>Hyperlipidemia E78.5 ; Primary OA M15.0 ; Nevus, non-neoplastic I78.1 ; Marijuana use F12.90 ; Alcohol dependence, daily use F10.20 ; COVID-19 vaccination declined Z28.21 ; BMI 25-25.9 Z68.25 ; Dietary counseling Z71.3 ; Annual visit for general adult medical examination with abnormal findings Z00.01 ; Cervicalgia M54.2 and Immunization not carried out because of patient refusal Z28.21</td></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>08/14/2023</td><td>Chirag Patel</td><td>Primary OA M15.0</td></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>10/23/2023</td><td>Chirag Patel</td><td>Primary OA M15.0</td></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>11/21/2023</td><td>Chirag Patel</td><td/></tr><tr><td>MCM Hudson Lakeshore Blvd 1</td><td>13906 LAKESHORE BLVD Suite 330 HUDSON, FL 346671487</td><td>02/19/2024</td><td>Chirag Patel</td><td/></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">06/21/2023</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td>controlled with diet</td><td/></tr><tr><td ID="ref2">06/21/2023</td><td>Primary OA (ICD-10 - M15.0)</td><td/><td>controlled on current medication</td><td/></tr><tr><td ID="ref3">06/14/2023</td><td>HLD (HYPERLIPIDEMIA) (ICD-10 - E78.5)</td><td/><td/><td/></tr><tr><td ID="ref4">12/20/2023</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td>controlled with diet</td><td/></tr><tr><td ID="ref5">12/20/2023</td><td>Primary OA (ICD-10 - M15.0)</td><td/><td>controlled on current medication</td><td/></tr><tr><td ID="ref6">12/13/2023</td><td>Hyperlipidemia (ICD-10 - E78.5)</td><td/><td/><td/></tr><tr><td ID="ref7">08/14/2023</td><td>Primary OA (ICD-10 - M15.0)</td><td/><td/><td/></tr><tr><td ID="ref8">10/23/2023</td><td>Primary OA (ICD-10 - M15.0)</td><td/><td/><td/></tr><tr><td ID="ref9">12/20/2023</td><td>Nevus, non-neoplastic (ICD-10 - I78.1)</td><td/><td>declines derm eval states hereditary, and wants conservative mx</td><td/></tr><tr><td ID="ref10">06/21/2023</td><td>Nevus, non-neoplastic (ICD-10 - I78.1)</td><td/><td>declines derm eval states hereditary, and wants conservative mx</td><td/></tr><tr><td ID="ref11">06/21/2023</td><td>Marijuana use (ICD-10 - F12.90)</td><td/><td> cessation advised</td><td/></tr><tr><td ID="ref12">12/20/2023</td><td>Marijuana use (ICD-10 - F12.90)</td><td/><td> cessation advised</td><td/></tr><tr><td ID="ref13">12/20/2023</td><td>Alcohol dependence, daily use (ICD-10 - F10.20)</td><td/><td> Advised to cut back on etoh</td><td/></tr><tr><td ID="ref14">06/21/2023</td><td>Alcohol dependence, daily use (ICD-10 - F10.20)</td><td/><td> Advised to cut back on etoh</td><td/></tr><tr><td ID="ref15">06/21/2023</td><td>COVID-19 vaccination declined (ICD-10 - Z28.21)</td><td/><td>declines vaccine</td><td/></tr><tr><td ID="ref16">12/20/2023</td><td>COVID-19 vaccination declined (ICD-10 - Z28.21)</td><td/><td>declines vaccine</td><td/></tr><tr><td ID="ref17">12/20/2023</td><td>BMI 25-25.9 (ICD-10 - Z68.25)</td><td/><td>wt. management discussed</td><td/></tr><tr><td ID="ref18">06/21/2023</td><td>BMI 25-25.9 (ICD-10 - Z68.25)</td><td/><td>wt. management discussed</td><td/></tr><tr><td ID="ref19">06/21/2023</td><td>Dietary counseling (ICD-10 - Z71.3)</td><td/><td>Patient advised to have GI follow-up; he has never had a colonoscopy; he declines; dietary recommendations</td><td/></tr><tr><td ID="ref20">12/20/2023</td><td>Dietary counseling (ICD-10 - Z71.3)</td><td/><td>Patient advised to have GI follow-up; he has never had a colonoscopy; he declines; dietary recommendations</td><td/></tr><tr><td ID="ref21">12/20/2023</td><td>Annual visit for general adult medical examination with abnormal findings (ICD-10 - Z00.01)</td><td/><td>Health promotion discussed</td><td/></tr><tr><td ID="ref22">06/21/2023</td><td>Annual visit for general adult medical examination with abnormal findings (ICD-10 - Z00.01)</td><td/><td>Health promotion discussed</td><td/></tr><tr><td ID="ref23">12/20/2023</td><td>Cervicalgia (ICD-10 - M54.2)</td><td/><td>Patient is going to try the chiropractor; order x-rays patient reports will call after complete</td><td/></tr><tr><td ID="ref24">12/20/2023</td><td>Immunization not carried out because of patient refusal (ICD-10 - Z28.21)</td><td/><td/><td/></tr><tr><td ID="ref25">06/21/2023</td><td>Other</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">X ray : Spines, cervical</td><td>12/20/2023</td></tr><tr><td ID="pendingTest2">CBC With Differential/Platelet-005009</td><td>12/20/2023</td></tr><tr><td ID="pendingTest3">Lipid Panel-303756</td><td>12/20/2023</td></tr><tr><td ID="pendingTest4">TSH reflex to T4F-316487</td><td>12/20/2023</td></tr><tr><td ID="pendingTest5">CMP14+eGFR-334943</td><td>12/20/2023</td></tr><tr><td ID="pendingTest6">FECAL GLOBIN BY IMMUNOCHEM. (MEDICARE) (11293)</td><td>12/17/2021</td></tr></tbody></table><span class="content_span">Future Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="futureTest1">CHEST PA &amp; LATERAL</td><td>10/10/2022</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:Chirag Patel, 06/13/2024 08:00:00 AM, 13906 LAKESHORE BLVD, Suite 330, HUDSON, FL, 346671487, 727-863-5242</td></tr><tr><td ID="futureAppt2">Provider Name:Chirag Patel, 06/20/2024 09:45:00 AM, 13906 LAKESHORE BLVD, Suite 330, HUDSON, FL, 346671487, 727-863-5242</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Careplus MCR</td><td>PO BOX 31286 TAMPA, FL 33631-3320</td><td>866-220-5448</td><td>3974819</td><td/><td>Brunner, Michael</td><td>Self - patient is the insured</td><td>11/01/2021</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>OA (knees)</td><td/></tr><tr><td>ETOH dependance</td><td/></tr><tr><td>Marijuana use</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>mamry mastectomy-left breast</td><td>1972</td></tr><tr><td>hernia right groin</td><td>2003</td></tr></tbody></table><span class="content_span">Hospitalization History</span><table width="100%" border="1"><thead><tr><th>Reason</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>mamry mastectomy</td><td>1972</td></tr></tbody></table></div><h3><a name="id18" href="#toc">Progress Notes</a></h3><div>No Information</div><br/><br/></body></html>